PTC124 for cystic fibrosis - Authors' reply

Eitan Kerem; Batsheva Kerem; Ellen M. Welch; Christopher Trotta; Marla Weetall; Langdon Miller; Allan Jacobson; Stuart W. Peltz

doi:10.1016/S0140-6736(09)60820-5

PTC124 for cystic fibrosis - Authors' reply

Eitan Kerem^*
, Batsheva Kerem
, Ellen M. Welch
, Christopher Trotta
, Marla Weetall
, Langdon Miller
, Allan Jacobson
, Stuart W. Peltz

^*Corresponding author for this work

Department of Genetics

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1426-1427
Number of pages	2
Journal	The Lancet
Volume	373
Issue number	9673
DOIs	https://doi.org/10.1016/S0140-6736(09)60820-5
State	Published - 2009

Bibliographical note

Funding Information:
EK and BK received funding support from PTC Therapeutics for this study. EMW, CT, MW, LM, and SWP are employees of PTC Therapeutics. AJ has no conflicts of interest.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0140-6736(09)60820-5

Cite this

@article{ec23ffc54a864142a49f19c0c68669ad,

title = "PTC124 for cystic fibrosis - Authors' reply",

author = "Eitan Kerem and Batsheva Kerem and Welch, \{Ellen M.\} and Christopher Trotta and Marla Weetall and Langdon Miller and Allan Jacobson and Peltz, \{Stuart W.\}",

note = "Funding Information: EK and BK received funding support from PTC Therapeutics for this study. EMW, CT, MW, LM, and SWP are employees of PTC Therapeutics. AJ has no conflicts of interest.",

year = "2009",

doi = "10.1016/S0140-6736(09)60820-5",

language = "אנגלית",

volume = "373",

pages = "1426--1427",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "9673",

}

TY - JOUR

T1 - PTC124 for cystic fibrosis - Authors' reply

AU - Kerem, Eitan

AU - Kerem, Batsheva

AU - Welch, Ellen M.

AU - Trotta, Christopher

AU - Weetall, Marla

AU - Miller, Langdon

AU - Jacobson, Allan

AU - Peltz, Stuart W.

N1 - Funding Information: EK and BK received funding support from PTC Therapeutics for this study. EMW, CT, MW, LM, and SWP are employees of PTC Therapeutics. AJ has no conflicts of interest.

PY - 2009

Y1 - 2009

UR - https://www.scopus.com/pages/publications/64949125105

U2 - 10.1016/S0140-6736(09)60820-5

DO - 10.1016/S0140-6736(09)60820-5

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

AN - SCOPUS:64949125105

SN - 0140-6736

VL - 373

SP - 1426

EP - 1427

JO - The Lancet

JF - The Lancet

IS - 9673

ER -

PTC124 for cystic fibrosis - Authors' reply

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this